Carbapenem resistance among acinetobacter baumannii isolates is rapidly increasing and has been widely implicated in nosocomial infections and hospital outbreaks. No specific guidelines exist addressing the prevention and management of a. Task force on management and prevention of acinetobacter. It can also colonize or live in a patient without causing infections or symptoms, especially in respiratory secretions sputum or open wounds. These strains have been isolated in different countries since the early. Overall, between 1999 and 2012, cephr and cr a baumannii isolates increased in children. Acinetobacter baumannii resistance trends in children in. Summary carbapenemresistant gramnegative bacteria, in particular the acineto bacter baumanniicalcoaceticus complexandenterobacteriaceae,areescalatingglobal public health threats. Antimicrobial susceptibility of acinetobacter baumannii isolated from hospital patients wanutsanun tunyapanit a. Use of adjunctive aerosolized antimicrobial therapy in the. Accumulation of antibiotic resistance genes in carbapenem.
Acinetobacter baumannii can cause infections in the blood, urinary tract, and lungs pneumonia, or in wounds in other parts of the body. Structural basis for acinetobacter baumannii biofilm. However, knowledge of the genomic aspects of crab from many parts of the world is still limited. Antibioticresistant acinetobacter baumannii is associated with nosocomial infections worldwide. Crabbsi patients receiving tigecycline therapy or cefoperazonesulbactam therapy between january 2012 and december 2017 was enrolled, and strict exclusion criteria were followed. Large randomized trials are required to define the role of adjunctive aerosolized antibiotics in gramnegative vap. Healthcare provider information sheet for acinetobacter. During 2012 2015, we conducted laboratory and populationbased surveillance in selected metropolitan areas in. Vertebrates have evolved mechanisms to sequester zn from invading pathogens by a process termed nutritional immunity. Signal transduction proteins in acinetobacter baumannii. The most important mechanisms in acquiring carbapenem resistance in a.
Importance acinetobacter baumannii is the causative agent of hospitalacquired infections, including pneumonia and serious blood and wound infections. Acinetobacter baumannii resistance to amikacin showed the highest absolute increase in resistance rates 9. Environmental contamination by carbapenemresistant acinetobacter baumannii. Acinetobacter baumannii is an opportunistic pathogen that has emerged as a prevalent source of nosocomial infections, most frequently causing ventilator. Acinetobacter baumannii is an opportunistic pathogen or coloniser of hospitalised patients, especially severely unwell patients on intensive care units. Following their traditional role, the two component systems tcss present in a. In addition to causing severe disease in hospitalized patients, a.
The worldwide distribution of carbapenemresistant acinetobacter baumannii crab has become a global concern, particularly in countries where antibiotic prescription is not tightly regulated. A full list of acinetobacter species is provided in etable 3151. Defining genephenotype relationships in acinetobacter. From february 2012 to october 20, a total of 73 water samples, 51 soil samples, 37 raw cow milk samples, 50 cow meat samples, 7 raw cheese samples, and 379 animal samples were analyzed by. Gramnegative bacteria, such as acinetobacter baumannii, are an increasing burden in hospitals worldwide with an alarming spread of multidrug resistant mdr strains. In the context of this chapter, the term acinetobacter species refers specifically to acinetobacter baumannii and acinetobacter baumanniicalcoaceticus complex. Herein, we compared a type strain atcc17978, a nonclinical isolate dsm30011 and mdr strains of a. The objective of our study was to explore the extrahospital epidemiology of a. An acinetobacter baumannii, zincregulated peptidase. Atlanta, georgia estimated carbapenemnonsusceptible acinetobacter baumannii, 8 us metropolitan areas, 2012 2015.
Acinetobacter baumannii maintains its virulence after long. Acinetobacter baumannii is an emerging opportunistic bacterial pathogen of increasing concern due to multidrug resistance. The acinetobacter superbug can cause diseases such as pneumonia and meningitis. Acinetobacter baumannii is a notorious pathogen in health care settings around the world, primarily due to high resistance to antibiotics. The xray structure of the csuccsue chaperoneadhesin preassembly complex reveals the. We report a cluster of highly resistant acinetobacter baumannii that occurred in a burn icu over 5 months and then spread to a separate icu. Efficacy of highdose nebulized colistin in ventilatorassociated pneumonia caused by multidrugresistant pseudomonas aeruginosa and acinetobacter baumannii. Acinetobacter baumannii constitutes a dreadful problem in many icus worldwide. It is a frequent cause of pneumonia and septicemia in immunocompromised patients. Acinetobacter baumannii is a cause of healthcareassociated infections. Acinetobacter baumannii is an opportunistic bacterial pathogen primarily associated with hospitalacquired infections. Patients with pseudomonas aeruginosa and acinetobacter baumannii vap may have better survival with adjunctive aerosolized antibiotics, despite greater severity of illness and a greater incidence of multidrugresistant infection. Characterization of an acinetobacter baumannii lptd. Methods surveillance catchment area surveillance was populationbased and conducted in 3 metropolitan areas in 2012.
The recent increase in incidence, largely associated with infected combat troops returning from conflict zones, coupled with a dramatic increase in the incidence of multidrugresistant mdr strains, has significantly raised the profile of this emerging opportunistic pathogen. Inhibition of lpxc protects mice from resistant acinetobacter baumannii by modulating inflammation and enhancing phagocytosis. Biofilm and antibiotic resistance in acinetobacter baumannii. Acinetobacter baumannii named in honor of the american bacteriologists paul and linda baumann is a gramnegative, multidrugresistant mdr pathogen that causes nosocomial infections, especially in intensive care units icus and immunocompromised patients with central venous catheters. The effects of room type and cleaning methods volume 41 issue 2 anat or lerner, jalal abuhanna, yehuda carmeli, vered schechner. Acinetobacter baumannii, a nonfermenter gramnegative coccobacillus, was considered a lowcategory pathogen in the past, but has now emerged as a leading cause of hospital and communityacquired infections.
This study aimed to define the taxonomic status of a phenetically distinct group of 16 strains that corresponds to acinetobacter genomic species close to tu, a provisional genomic species of the acinetobacter calcoaceticusacinetobacter baumannii acb complex recognized by gernersmidt and tjernberg in 1993. Acinetobacter baumannii, multidrug resistance, resistant gene, genotyping. The recent increase in incidence, largely associated with infected combat. Bahador a, taheri m, pourakbari b, hashemizadeh z, rostami h, mansoori n et al 20 emergence of rifampicin, tigecycline, and colistinresistant acinetobacter baumannii in iran. While there are many species of acinetobacter that can cause human disease, acinetobacter baumannii a. Ab5075, a highly virulent isolate of acinetobacter. Acinetobacter baumannii is a typically short, almost round, rodshaped coccobacillus gramnegative bacterium. The presence of acinetobacter baumannii outside hospitals is still a controversial issue.
Under the microscope, it looks halfway between a rod and a ball. Comparison of tigecycline or cefoperazonesulbactam. Efficacy of highdose nebulized colistin in ventilator. The very limited therapeutic options available for these organisms are a matter of great concern. Acinetobacter baumannii resistance trends in children in the. Acinetobacter baumannii is an important nosocomial pathogen capable of causing wound infections, pneumonia, and bacteremia. First report of blandm1producing acinetobacter baumannii. Biofilm formation is mediated by csu pili, assembled via the archaic chaperoneusher pathway. Although the studies related to the animal infections caused by. Acinetobacter baumanniia leading cause of nosocomial infectionshas a remarkable capacity to persist in hospital environments and medical devices due to its ability to form biofilms. We retrospectively analyzed the effect of tigecycline and cefoperazonesulbactam therapies on the prognosis of patients with carbapenemresistant acinetobacter baumannii bloodstream infection crabbsi.
Acinetobacter baumannii is a bacterium that can cause a range of diseases. Acinetobacter baumannii is recognized as an emerging bacterial pathogen because of traits such as prolonged survival in a desiccated state, effective nosocomial transmission, and an inherent ability to acquire antibiotic resistance genes. Extrahuman epidemiology of acinetobacter baumannii in. Antimicrobial susceptibility of acinetobacter baumannii. Carbapenemnonsusceptible acinetobacter baumannii, 8 us.
1565 157 1023 910 1551 288 968 1364 275 42 1234 585 1292 805 381 1247 1065 581 751 1092 832 23 935 1024 445 544 918 245 322